Cellectar Biosciences (CLRB) Non-Current Assets (2010 - 2026)
Cellectar Biosciences (CLRB) posted Non-Current Assets of $1.76 million for Q2 2026, up 63.5% from $1.08 million a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Cellectar Biosciences' Non-Current Assets came in at $939,856, down 23.2% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of 5.5% (FY2020 to FY2025).
- In prior years, Cellectar Biosciences' Non-Current Assets was $1.22 million in FY2024 (-24.6%), $1.62 million in FY2023 (+53.0%), $1.06 million in FY2022 (+68.2%) and $630,349 in FY2021 (-12.4%).
- The Q2 2026 figure stands as the highest quarterly Non-Current Assets since Q3 2018.
- On a year-over-year basis, Non-Current Assets increased in 1 of the last seven quarters, with an average decline of 9.7%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2023, with growth of 158.1%; the weakest was Q3 2021, with a decline of 37.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Cellectar Biosciences | 22.26 Mn | 22.26 Mn | - | 1.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Dec 31, 2025 | 939,856.00 |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 899,514.00 |
| Mar 31, 2023 | 992,020.00 |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 558,255.00 |
| Jun 30, 2022 | 607,163.00 |
| Mar 31, 2022 | 595,644.00 |
| Dec 31, 2021 | 630,349.00 |
| Sep 30, 2021 | 560,460.00 |
| Jun 30, 2021 | 612,975.00 |
API Access
Cellectar Biosciences Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();